Coriolis Pharma
Martinsried, Germany coriolis-pharma.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Coriolis Pharma provides drug product development, analytical services, and manufacturing services for biopharmaceutical products. It serves pharmaceutical and biotech partners from preclinical through commercialization under R&D and GMP conditions, with headquarters in Martinsried near Munich and a U.S. office in Durham, North Carolina.
Services
Drug Product Development Accelerator Development Platforms
Standardized development platform services intended to speed Phase I clinical trial readiness and support developability and formulatability assessment.
In Silico Modeling
AI- and data-driven modeling to assess molecule behavior early and support development decisions.
Preformulation Studies
Developability assessment and preformulation screening to identify suitable formulation conditions before first-in-human development.
Formulation Development Services
Development of robust liquid, frozen, and lyophilized formulations for biopharmaceutical drug products.
Comparability Studies
Studies to compare product or process changes during development and lifecycle management.
Stability Studies
Stability testing services for development, release, and commercialization needs.
In-Use Stability Studies
Assessment of stability after product use or preparation for administration.
Forced Degradation Studies
Studies designed to intentionally stress drug products to understand degradation behavior.
12 more services
- Biopharmaceutical Process Development
- Wet-Lab Developability and Formulatability Assessment
- Fast-Track Analytics
- Method Development and Validation
- Aggregate Analytics
- Particle Characterization
- Particle Identification
- Surfactant Characterization
- Higher-Order Structure Analysis
- Functional Assays
- Chemical Change Analysis
- Container Closure and Integrity Testing
Capabilities
- Assays and studies
- Stability studies
- Antibodies
- Lyophilization
- Process development
- Peptides
- Cell therapy
14 more
- Aggregate analytics
- Particle characterization
- Particle identification
- Surfactant characterization
- Higher-order structure analysis
- Functional assays
- Chemical change analysis
- Container closure integrity testing
- Basic formulation characterization
- Stability testing
- Release testing
- Method development and validation
- Fast-track analytics
- Lyophilizate analytical services
- Scale and capacity
- 3,600+ sqm R&D and GMP lab space
- 200+ analytical devices
- Automated filling line
- Manual filling capacities
- Non-GMP manufacturing and lyophilization capabilities
Instruments and platforms
- Analytical ultracentrifugation (AUC)
- HPLC
Modalities and species
- Modalities
- Antibody
- Peptide
- Viral vector
- Cell therapy
- Vaccine
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
As listed: GMP conditions
Details
- Type
- CRO
- Office
- 8 Davis Drive, Suite 324 Durham, NC 27713, United States
- Sites
- Durham, NC, United States
- Serves
- Global
Public records
- FDA drug establishment registration
- 3014060629 · ANALYSIS source